Archive for August, 2013
Recent Rosacea Blog Posts
What sort of benefit might you expect from using Mirvaso to treat your rosacea redness? Well, Galderma has made available some publicity photographs that show before and after photographs from the Mirvaso Clinical Trials. These photographs also appeared in the journal of drugs in dermatology article describing the development and analysis of Mirvaso’s active ingredient […]
A recently published paper introduces us to a new form of at-home therapy based on high frequency ultrasound. The Skinova treatment using sound waves at a very high frequency of 10 MHz. This allows treatments to a depth of around 0.3cm. At this depth we are told that “the effect is mainly concentrated on the […]
The just approved Mirvaso is a milestone in the long development and approval process. Rosacea sufferers have watched this drug since as early as 2004 when patents started emerging. Now that Mirvaso has been officially approved by the FDA more information about the final formulation has emerged. From the Mirvaso Prescribing Information we can see […]
Surprise news today that Mirvaso, the product formerly known as Sansrosa, CD07805/47 and Col-118 has been granted approval by the FDA. Here are some of the things we already know about Mirvaso ; The prescription gel will be 0.33% brimonidine (this means each gram of the gel contains 5mg of birmonidine tartrate, which is the […]
News today that Galderma has succeeded in gaining FDA Approval for Mirvaso – the brand name chosen for the product that during development was known as Sansrosa, CD07805/47 and Col-118. The Brimonidine Tartrate 0.33% Topical Gel is expected to be available as soon as next month. Great news that approval has been granted after so […]
